/PRNewswire/ Cytrellis Biosystems, a pioneer in novel medical aesthetic solutions and manufacturer of ellacorĀ® and its proprietary Micro-CoringĀ® Technology,.
/PRNewswire/ Pharmaceutical Excipients Market in terms of revenue was estimated to be worth $10.0 billion in 2023 and is poised to reach $13.9 billion by.
/PRNewswire/ Digital Polymerase Chain Reaction (PCR) Market is Segmented by Technology (Droplet Digital Pcr, Chip Based Digital Pcr, Beaming Digital Pcr),.
Aligned with the FDA on submitted protocol for 225Ac-PSMA (FPI-2265) Phase 2/3 registrational program for patients with metastatic castration-resistant.